Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease

The Lancet Oncology

Volumn 10, Issue 8, 2009, Pages 801-809

  Carpizo, Darren R ^a   D'Angelica, Michael ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; COMORBIDITY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; HUMAN; LIVER DISEASE; LIVER METASTASIS; LIVER RESECTION; LUNG METASTASIS; LUNG RESECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MEDICAL DECISION MAKING; MEDICAL RESEARCH; OVERALL SURVIVAL; PATIENT SELECTION; PELVIS LYMPH NODE; PERITONEUM METASTASIS; PERITONITIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL APPROACH; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; PERITONEAL NEOPLASMS;

EID: 67651180709     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70081-6     Document Type: Review

References (51)

1. Tomlinson J.S., Jarnagin W.R., DeMatteo R.P., et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25 (2007) 4575-4580
2. Adson M.A., van Heerden J.A., Adson M.H., Wagner J.S., and Ilstrup D.M. Resection of hepatic metastases from colorectal cancer. Arch Surg 119 (1984) 647-651
3. Ekberg H., Tranberg K.G., Andersson R., et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73 (1986) 727-731
4. Hughes K.S., Simon R., Songhorabodi S., et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 100 (1986) 278-284
5. Blumgart L.H., and Fong Y. Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Probl Surg 32 (1995) 333-421
6. Falcone A., Masi G., Allegrini G., et al. Biweekly chemotherapy with oxaliplatin, irinotecan, infusional fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer. J Clin Oncol 20 (2002) 4006-4014
7. Seium Y., Stupp R., Ruhstaller T., et al. Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study. Ann Oncol 16 (2005) 762-766
8. Sheikh H.Y., Valle J.W., Palmer K., et al. Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a phase I study. Br J Cancer 96 (2007) 38-43
9. August D.A., Sugarbaker P.H., and Schneider P.D. Lymphatic dissemination of hepatic metastases. Implications for the follow-up and treatment of patients with colorectal cancer. Cancer 55 (1985) 1490-1494
10. Beckurts K.T., Holscher A.H., Thorban S., Bollschweiler E., and Siewert J.R. Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg 84 (1997) 1081-1084
11. Rosen C.B., Nagorney D.M., Taswell H.F., et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216 (1992) 493-504
12. Kokudo N., Sato T., Seki M., et al. Hepatic lymph node involvement in resected cases of liver metastases from colorectal cancer. Dis Colon Rectum 42 (1999) 1285-1290
13. Elias D., Saric J., Jaeck D., et al. Prospective study of microscopic lymph node involvement of the hepatic pedicle during curative hepatectomy for colorectal metastases. Br J Surg 83 (1996) 942-945
14. Ercolani G., Grazi G.L., Ravaioli M., et al. The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg 239 (2004) 202-209
15. Grobmyer S.R., Wang L., Gonen M., et al. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg 244 (2006) 260-264
16. Jaeck D., Nakano H., Bachellier P., et al. Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Ann Surg Oncol 9 (2002) 430-438
17. Laurent C., Sa Cunha A., Rullier E., Smith D., Rullier A., and Saric J. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis. J Am Coll Surg 198 (2004) 884-891
18. Adam R., de Haas R.J., Wicherts D.A., et al. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?. J Clin Oncol 26 (2008) 3672-3680
19. Fortner J.G., Silva J.S., Golbey R.B., Cox E.B., and Maclean B.J. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 199 (1984) 306-316
20. Bennett J.J., Schmidt C.R., Klimstra D.S., et al. Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases. Ann Surg Oncol 15 (2008) 1130-1136
21. Tan L.K., Giri D., Hummer A.J., et al. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol 26 (2008) 1803-1809
22. Adam R., Pascal G., Castaing D., et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?. Ann Surg 240 (2004) 1052-1061
23. Fong Y., Fortner J., Sun R.L., Brennan M.F., and Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309-318
24. Sadahiro S., Suzuki T., Ishikawa K., et al. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology 50 (2003) 1362-1366
25. Ashley A.C., Deschamps C., and Alberts S.R. Impact of prognostic factors on clinical outcome after resection of colorectal pulmonary metastases. Clin Colorectal Cancer 6 (2006) 32-37
26. Miller G., Biernacki P., Kemeny N.E., et al. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg 205 (2007) 231-238
27. Kobayashi K., Kawamura M., and Ishihara T. Surgical treatment for both pulmonary and hepatic metastases from colorectal cancer. J Thorac Cardiovasc Surg 118 (1999) 1090-1096
28. Nagakura S., Shirai Y., Yamato Y., Yokoyama N., Suda T., and Hatakeyama K. Simultaneous detection of colorectal carcinoma liver and lung metastases does not warrant resection. J Am Coll Surg 193 (2001) 153-160
29. Mineo T.C., Ambrogi V., Tonini G., et al. Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma. J Am Coll Surg 197 (2003) 386-391
30. Reddy R.H., Kumar B., Shah R., et al. Staged pulmonary and hepatic metastasectomy in colorectal cancer-is it worth it?. Eur J Cardiothorac Surg 25 (2004) 151-154
31. Shah S.A., Haddad R., Al-Sukhni W., et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 202 (2006) 468-475
32. Iizasa T., Suzuki M., Yoshida S., et al. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Ann Thorac Surg 82 (2006) 254-260
33. Kanemitsu Y., Kato T., Hirai T., and Yasui K. Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg 91 (2004) 112-120
34. Welter S., Jacobs J., Krbek T., Poettgen C., and Stamatis G. Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer. Eur J Cardiothorac Surg 31 (2007) 167-172
35. Jayne D.G., Fook S., Loi C., and Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89 (2002) 1545-1550
36. Koppe M.J., Boerman O.C., Oyen W.J., and Bleichrodt R.P. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 243 (2006) 212-222
37. Yan T.D., Black D., Savady R., and Sugarbaker P.H. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 24 (2006) 4011-4019
38. Verwaal V.J., van Ruth S., de Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21 (2003) 3737-3743
39. Verwaal V.J., Bruin S., Boot H., van Slooten G., and van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15 (2008) 2426-2432
40. Elias D., Dube P., Bonvalot S., et al. Treatment of liver metastases with moderate peritoneal carcinomatosis by hepatectomy and cytoreductive surgery followed by immediate post-operative intraperitoneal chemotherapy: feasibility and preliminary results. Hepatogastroenterology 46 (1999) 360-363
41. Elias D., Benizri E., Pocard M., Ducreux M., Boige V., and Lasser P. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol 32 (2006) 632-636
42. Carmignani C.P., Ortega-Perez G., and Sugarbaker P.H. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer. Eur J Surg Oncol 30 (2004) 391-398
43. Kianmanesh R., Scaringi S., Sabate J.M., et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg 245 (2007) 597-603
44. Elias D., Ouellet J.F., Bellon N., Pignon J.P., Pocard M., and Lasser P. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 90 (2003) 567-574
45. Adson M.A. Resection of liver metastases-when is it worthwhile?. World J Surg 11 (1987) 511-520
46. Elias D., Sideris L., Pocard M., et al. Results of R0 resection for colorectal liver metastases associated with extrahepatic disease. Ann Surg Oncol 11 (2004) 274-280
47. Elias D., Liberale G., Vernerey D., et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 12 (2005) 900-909
48. Strasberg S. Letter to the editor. Ann Surg Oncol 14 (2007) 1517-1518
49. Aoki T., Umekita N., Tanaka S., Noda K., Warabi M., and Kitamura M. Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin. Surgery 143 (2008) 706-714
50. Steele Jr. G., and Ravikumar T.S. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 210 (1989) 127-138
51. Malik H.Z., Prasad K.R., Halazun K.J., et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 246 (2007) 806-814